United States · Markets & Finance · Washington Post Business

Health Brief: Eli Lilly takes on retatrutide copycats

Published by Washington Post Business · United States 14 h ago

Eli Lilly is suing five more companies accused of selling illicit copies of its experimental weight loss drug retatrutide as CEO Dave Ricks presses regulators to do more Insurers…

Read the full article on Washington Post Business Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.washingtonpost.com)

Also worth reading

CoinDesk

XRP Ledger patched decade-old bug that could create billions of dollars in XRP from nothing

Business Insider

Trump's AI rebrand is catching on with Elon Musk and Marc Benioff

TechCrunch

Elon Musk intensifies attack on Ambani over Starlink India launch delay

CNBC

Trump's diesel agreement with Putin accused of contradicting Russia sanctions law

Seeking Alpha

Trump turns to Russia in bid to lower diesel prices, but analysts see minimal impact

NYT Business